Stephen R D Johnston

No ORCID on file · 1 paper in corpus
review 2002
Fulvestrant (AstraZeneca)
Current opinion in investigational drugs (London, England : 2000)

Fulvestrant (Faslodex) is an estrogen receptor (ER) downregulator under development by AstraZeneca for the potential treatment of breast cancer [172191], [237518], [314472], [349551]. In March 2001, an NDA was filed in the US for the second…